Revealing the Polioviruss Path to Infection.
- Published in:
- PLoS Biology, 2007, v. 5, n. 7, p. e205, doi. 10.1371/journal.pbio.0050205
- By:
- Publication type:
- Article
Works matching DE "POLIOVIRUS"
Results: 1181
1
2
Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2019, v. 166, n. 6, p. 111, doi. 10.1007/s10517-019-04472-6
- By:
- Publication type:
- Article
3
Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2016, v. 161, n. 6, p. 821, doi. 10.1007/s10517-016-3520-1
- By:
- Publication type:
- Article
4
Progress Toward Poliomyelitis Eradication -- India, 2003.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2004, v. 53, n. 11, p. 238
- Publication type:
- Article
5
Labotarory Surveillance for Wild and Vaccine-Derived Polioviruses, January 2002-June 2003.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2003, v. 52, n. 38, p. 913
- Publication type:
- Article
6
Progress Toward Poliomyelitis Eradication--Afghanistan and Pakistan, January 2002-May 2003.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2003, v. 52, n. 29, p. 683
- Publication type:
- Article
7
Global Progress Toward Laboratory Containment of Wild Polioviruses -- July 2001-August 2002.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2002, v. 51, n. 44, p. 993
- Publication type:
- Article
8
Progress Toward Poliomyelitis Eradication--India, Bangladesh, and Nepal, January 2001-June 2002.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2002, v. 51, n. 37, p. 831
- Publication type:
- Article
9
Certification of Poliomyelitis Eradication--European Region, June 2002.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2002, v. 51, n. 26, p. 572
- Publication type:
- Article
10
Laboratory Surveillance for Wild Poliovirus and Vaccine-Derived Poliovirus, 2000-2001.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2002, v. 51, n. 17, p. 369
- Publication type:
- Article
11
Progress Toward Global Eradication of Poliomyelitis, 2001.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2002, v. 51, n. 12, p. 253
- Publication type:
- Article
12
Acute Flaccid Paralysis Associated with Circulating Vaccine-Derived Poliovirus -- Philippines, 2001.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2001, v. 50, n. 40, p. 874
- Publication type:
- Article
13
Progress Toward Poliomyelitis Eradication--Angola, Democratic Republic of Congo, Ethiopia, and Nigeria, January 2000-July 2001.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2001, v. 50, n. 38, p. 826
- Publication type:
- Article
14
Global Progress Toward Laboratory Containment of Wild Polioviruses, June 2001.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2001, v. 50, n. 29, p. 620
- Publication type:
- Article
15
Update: Assessment of Risk for Meningococcal Disease Associated With the Hajj 2001.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2001, v. 50, n. 12, p. 221
- Publication type:
- Article
16
Circulation of a Type 2 Vaccine-Derived Poliovirus -- Egypt, 1982-1993.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2001, v. 50, n. 3, p. 41
- Publication type:
- Article
17
Certification of Poliomyelitis Eradication--Western Pacific Region, October 2000.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2001, v. 50, n. 1, p. 1
- Publication type:
- Article
18
Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus.
- Published in:
- GeroScience, 2023, v. 45, n. 2, p. 707, doi. 10.1007/s11357-022-00672-7
- By:
- Publication type:
- Article
19
Synthesis of (Z)-(1-Fluoro-2-hydroxymethyl-cyclopropylmethyl)purines.
- Published in:
- Nucleosides, Nucleotides & Nucleic Acids, 2003, v. 22, n. 5-8, p. 659, doi. 10.1081/NCN-120022605
- By:
- Publication type:
- Article
20
Synthesis of [1′-Fluoro-2′,2′-bis-(hydroxymethyl)-cyclopropylmethyl]purines as Antiviral Agents.
- Published in:
- Nucleosides, Nucleotides & Nucleic Acids, 2003, v. 22, n. 5-8, p. 955, doi. 10.1081/NCN-120022694
- By:
- Publication type:
- Article
21
DESIGN AND SYNTHESIS OF NOVEL FLUOROCYCLOPROPANOID NUCLEOSIDES.
- Published in:
- Nucleosides, Nucleotides & Nucleic Acids, 2001, v. 20, n. 4-7, p. 677, doi. 10.1081/NCN-100002349
- By:
- Publication type:
- Article
22
NOVEL NUCLEOSIDES WITH VINYL FLUORIDE OR VINYL BROMIDE MOIETY AS OPEN-CHAIN ANALOGS OF NEPLANOCIN A.
- Published in:
- Nucleosides, Nucleotides & Nucleic Acids, 2001, v. 20, n. 4-7, p. 681, doi. 10.1081/NCN-100002350
- By:
- Publication type:
- Article
23
REACTOGENICITY AND MEDICALLY ATTENDED ADVERSE EVENTS FOLLOWING HEXAVALENT VACCINATION: AN OBSERVATIONAL PROSPECTIVE STUDY.
- Published in:
- Farmacia, 2019, v. 67, n. 6, p. 1018, doi. 10.31925/farmacia.2019.6.12
- By:
- Publication type:
- Article
24
Illustrating the machinery of life: Viruses.
- Published in:
- Biochemistry & Molecular Biology Education, 2012, v. 40, n. 5, p. 291, doi. 10.1002/bmb.20636
- By:
- Publication type:
- Article
25
SIRT-1 is required for release of enveloped enteroviruses.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.87993
- By:
- Publication type:
- Article
26
Persistence of echovirus and poliovirus in fermented sausages. Effects of sodium nitrite and processing variables
- Published in:
- Journal of Food Science (Wiley-Blackwell), 1975, v. 40, n. 5, p. 968
- By:
- Publication type:
- Article
27
MATLAB simulation based study on poliovirus sensing through one-dimensional photonic crystal with defect.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35595-6
- By:
- Publication type:
- Article
28
Editorial: Codon Usage and Dinucleotide Composition of Virus Genomes: From the Virus-Host Interaction to the Development of Vaccines.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.791750
- By:
- Publication type:
- Article
29
Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01826
- By:
- Publication type:
- Article
30
Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines.
- Published in:
- Clinical & Experimental Immunology, 1999, v. 117, n. 1, p. 100, doi. 10.1046/j.1365-2249.1999.00954.x
- By:
- Publication type:
- Article
31
Secretory IgA and IgM antibodies to E. coli O and poliovirus type I antigens occur in amniotic fluid, meconium and saliva from newborns.
- Published in:
- Clinical & Experimental Immunology, 1986, v. 63, n. 3, p. 555
- By:
- Publication type:
- Article
32
Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1.
- Published in:
- Cellular Microbiology, 2010, v. 12, n. 10, p. 1463, doi. 10.1111/j.1462-5822.2010.01482.x
- By:
- Publication type:
- Article
33
Cell permeabilization by poliovirus 2B viroporin triggers bystander permeabilization in neighbouring cells through a mechanism involving gap junctions.
- Published in:
- Cellular Microbiology, 2010, v. 12, n. 8, p. 1144, doi. 10.1111/j.1462-5822.2010.01460.x
- By:
- Publication type:
- Article
34
Viroporins from RNA viruses induce caspase-dependent apoptosis.
- Published in:
- Cellular Microbiology, 2008, v. 10, n. 2, p. 437, doi. 10.1111/j.1462-5822.2007.01057.x
- By:
- Publication type:
- Article
35
Poliomyelitis, 1971.
- Published in:
- Clinical Pediatrics, 1974, v. 13, n. 1, p. 15
- Publication type:
- Article
36
Poliomyelitis--United States, 1970. A Surveillance Summary.
- Published in:
- Clinical Pediatrics, 1972, v. 11, n. 3, p. 173
- Publication type:
- Article
37
DIAGNOSIS OF POLIOMYELITIS: Problems in the Laboratory.
- Published in:
- Clinical Pediatrics, 1963, v. 2, n. 11, p. 601, doi. 10.1177/000992286300201104
- By:
- Publication type:
- Article
38
Trivalent Oral Polio Vaccine: Clinical Trial of a New Formulation.
- Published in:
- Clinical Pediatrics, 1963, v. 2, n. 9, p. 517, doi. 10.1177/000992286300200909
- By:
- Publication type:
- Article
39
Polio eradication: mobilizing and managing the human resources.
- Published in:
- Bulletin of the World Health Organization, 2005, v. 83, n. 4, p. 268
- By:
- Publication type:
- Article
40
Polio case in Darfur sparks fears of epidemic in west and central Africa.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 7, p. 557
- Publication type:
- Article
41
Poliovirus vaccine strains will continue to circulate long after wild strains have been eradicated.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 65
- By:
- Publication type:
- Article
42
Containment of wild poliovirus in the laboratory is a realistic goal.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 64
- By:
- Publication type:
- Article
43
Can effective containment of wild polioviruses in laboratories and inactivated poliovirus vaccine production sites ever be achieved?
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 63
- By:
- Publication type:
- Article
44
Will the three steps for containment of poliovirus be enough to convince policy-makers?
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 63
- By:
- Publication type:
- Article
45
Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification?
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 59
- By:
- Publication type:
- Article
46
A developing country perspective on vaccine-associated paralytic poliomyelitis.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 53
- By:
- Publication type:
- Article
47
Polio control after certification: major issues outstanding.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 47
- By:
- Publication type:
- Article
48
Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 40
- By:
- Publication type:
- Article
49
The role of routine polio immunization in the post-certification era.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 31
- By:
- Publication type:
- Article
50
Certification of polio eradication: process and lessons learned.
- Published in:
- Bulletin of the World Health Organization, 2004, v. 82, n. 1, p. 24
- By:
- Publication type:
- Article